Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.925 | 0.120 | 6 | 154157305 | 3 prime UTR variant | C/A | snv | 0.52 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.800 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.925 | 0.120 | 6 | 154157305 | 3 prime UTR variant | C/A | snv | 0.52 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.925 | 0.120 | 6 | 154150090 | intron variant | G/A | snv | 0.54 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.925 | 0.120 | 6 | 154150090 | intron variant | G/A | snv | 0.54 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
6 | 154097624 | intron variant | A/G;T | snv |
|
0.700 | 1.000 | 1 | 2018 | 2018 | |||||||||||
|
6 | 154012048 | intron variant | T/C;G | snv |
|
0.700 | 1.000 | 1 | 2019 | 2019 | |||||||||||
|
0.559 | 0.600 | 6 | 154039662 | missense variant | A/G | snv | 0.19 | 0.12 |
|
Pathological Conditions, Signs and Symptoms | 0.100 | 0.979 | 47 | 2004 | 2019 | ||||||
|
0.559 | 0.600 | 6 | 154039662 | missense variant | A/G | snv | 0.19 | 0.12 |
|
Chemically-Induced Disorders; Mental Disorders | 0.100 | 0.893 | 28 | 1998 | 2019 | ||||||
|
0.559 | 0.600 | 6 | 154039662 | missense variant | A/G | snv | 0.19 | 0.12 |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms | 0.100 | 0.944 | 18 | 2006 | 2019 | ||||||
|
0.559 | 0.600 | 6 | 154039662 | missense variant | A/G | snv | 0.19 | 0.12 |
|
Chemically-Induced Disorders; Mental Disorders | 0.100 | 0.900 | 10 | 2001 | 2020 | ||||||
|
0.559 | 0.600 | 6 | 154039662 | missense variant | A/G | snv | 0.19 | 0.12 |
|
Behavior and Behavior Mechanisms | 0.090 | 1.000 | 9 | 2004 | 2019 | ||||||
|
0.559 | 0.600 | 6 | 154039662 | missense variant | A/G | snv | 0.19 | 0.12 |
|
Chemically-Induced Disorders; Mental Disorders | 0.070 | 0.857 | 7 | 2010 | 2018 | ||||||
|
0.559 | 0.600 | 6 | 154039662 | missense variant | A/G | snv | 0.19 | 0.12 |
|
Chemically-Induced Disorders; Mental Disorders | 0.070 | 0.857 | 7 | 2001 | 2017 | ||||||
|
0.559 | 0.600 | 6 | 154039662 | missense variant | A/G | snv | 0.19 | 0.12 |
|
Pathological Conditions, Signs and Symptoms | 0.070 | 0.857 | 7 | 2006 | 2019 | ||||||
|
0.559 | 0.600 | 6 | 154039662 | missense variant | A/G | snv | 0.19 | 0.12 |
|
Chemically-Induced Disorders; Mental Disorders | 0.060 | 1.000 | 6 | 2005 | 2018 | ||||||
|
0.559 | 0.600 | 6 | 154039662 | missense variant | A/G | snv | 0.19 | 0.12 |
|
Chemically-Induced Disorders; Mental Disorders | 0.060 | 0.833 | 6 | 2001 | 2016 | ||||||
|
0.559 | 0.600 | 6 | 154039662 | missense variant | A/G | snv | 0.19 | 0.12 |
|
Mental Disorders | 0.040 | 0.750 | 4 | 2010 | 2019 | ||||||
|
0.559 | 0.600 | 6 | 154039662 | missense variant | A/G | snv | 0.19 | 0.12 |
|
Behavior and Behavior Mechanisms | 0.030 | 0.667 | 3 | 2002 | 2015 | ||||||
|
0.559 | 0.600 | 6 | 154039662 | missense variant | A/G | snv | 0.19 | 0.12 |
|
Chemically-Induced Disorders; Mental Disorders | 0.030 | 0.667 | 3 | 2011 | 2017 | ||||||
|
0.559 | 0.600 | 6 | 154039662 | missense variant | A/G | snv | 0.19 | 0.12 |
|
Pathological Conditions, Signs and Symptoms | 0.030 | 1.000 | 3 | 2013 | 2019 | ||||||
|
0.559 | 0.600 | 6 | 154039662 | missense variant | A/G | snv | 0.19 | 0.12 |
|
Behavior and Behavior Mechanisms | 0.030 | 0.667 | 3 | 2002 | 2015 | ||||||
|
0.559 | 0.600 | 6 | 154039662 | missense variant | A/G | snv | 0.19 | 0.12 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.030 | 1.000 | 3 | 2012 | 2015 | ||||||
|
0.559 | 0.600 | 6 | 154039662 | missense variant | A/G | snv | 0.19 | 0.12 |
|
Pathological Conditions, Signs and Symptoms | 0.030 | 0.667 | 3 | 2011 | 2019 | ||||||
|
0.559 | 0.600 | 6 | 154039662 | missense variant | A/G | snv | 0.19 | 0.12 |
|
Mental Disorders | 0.030 | 0.667 | 3 | 2002 | 2015 | ||||||
|
0.559 | 0.600 | 6 | 154039662 | missense variant | A/G | snv | 0.19 | 0.12 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.030 | 1.000 | 3 | 2012 | 2015 |